PRKCA and ovarian carcinoma: For example, Arrighetti et al. found that miR-483 overexpression in ovarian cancer interferes with the proliferation of these tumour cells by targeting PRKCA (encoding PKC-α) and subsequently protects them from platinum-induced DNA damage [19].